| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regenxbio Inc. (RGNX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 43 sells. RGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $4.50M | - | |
| CEO | 342.5K | $3.11M | - | |
| Other | 247.9K | $2.25M | - | |
| Other | 215.4K | $1.95M | - | |
| Other | 82.2K | $745.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2018 | Danos Olivier | Chief Scientific Officer | Sale+OE | 20,000 | $63.80 | $1,275,913.92 | -48.9% | |
| Sep 17, 2018 | Mills Kenneth T.81 | President And CEO | Sell | 7,510 | $74.91 | $562,564.44 | -0.2% | |
| Sep 17, 2018 | Vasista Vittal79 | Chief Financial Officer | Sale+OE | 7,500 | $74.86 | $561,471.84 | -0.6% | |
| Aug 27, 2018 | Mills Kenneth T.81 | President And CEO | Sale+OE | 7,510 | $66.46 | $499,117.59 | -1.1% | |
| Aug 20, 2018 | Christmas Patrick J. | SVP, General Counsel | Sale+OE | 5,000 | $65.96 | $329,806.00 | -11.9% | |
| Aug 15, 2018 | Vasista Vittal79 | Chief Financial Officer | Sell | 7,500 | $65.43 | $490,709.68 | -3.0% | |
| Jul 16, 2018 | Vasista Vittal79 | Chief Financial Officer | Sell | 7,500 | $75.54 | $566,522.32 | -1.4% | |
| Jun 20, 2018 | Mills Kenneth T.81 | President And CEO | Sell | 5,000 | $66.20 | $331,017.50 | -0.5% | |
| Jun 18, 2018 | Christmas Patrick J. | SVP, General Counsel | Sale+OE | 5,000 | $56.78 | $283,886.00 | -11.9% | |
| Jun 15, 2018 | Vasista Vittal79 | Chief Financial Officer | Sell | 7,500 | $56.61 | $424,540.10 | -2.6% |